Answers are grounded in this paper and cite their sources.
The FVIII B-domain, a large and heavily glycosylated region, is crucial for FVIII secretion, though its structural and functional roles remain incompletely understood. While the B-domain is dispensable for cofactor activity, prior research hints at multiple, yet unverified, functional roles. Here, we employed an integrative hybrid approach to generate detailed structural models of glycosylated and furin-cleaved full-length FVIII (Gly/FC-FL-FVIII) that include the B-domain, utilizing AlphaFold2 (AF2) predictions. These models were further refined and validated with biophysical data from atomic force microscopy (AFM) and cryo-electron microscopy (cryo-EM) of recombinant and plasma-derived FL-FVIII proteins. Additionally, we modeled a FL-FVIII-VWF complex with both the B-domain and D′-D3 domains (FL-FVIII-VWF-D′-D3) to investigate B-domain interactions during intracellular processing. Our results suggest that the B-domain functions largely as an independent domain encircling the FVIII core. AFM studies revealed that VWF tails are associated with globular FVIII structures. Structural analysis indicated that B-domain glycosylation enhances stability, supports proper folding, and promotes efficient trafficking through the ER-Golgi pathway. We propose that, within the Golgi, the B-domain may unfold around FVIII via furin cleavages, facilitating essential interactions with partners such as VWF. Our models also suggest that the B-domain shields key FVIII epitopes, potentially reducing immune interference and inhibiting premature activation. This study presents a novel structural model of the FVIII B-domain and full-length FVIII, offering critical insights into previously unexplored aspects of B-domain function and its essential role in FVIII biology.
No takes yet. Share an insight, caveat, or question.
Urs et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: